Page last updated: 2024-10-26

valproic acid and Deficiency, Mental

valproic acid has been researched along with Deficiency, Mental in 86 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Research Excerpts

ExcerptRelevanceReference
"This is the first multicenter Italian experience with rufinamide as an adjunctive drug in children, adolescents and adults with Lennox-Gastaut syndrome."9.14Rufinamide in children and adults with Lennox-Gastaut syndrome: first Italian multicenter experience. ( Balestri, A; Capovilla, G; Coppola, G; Curatolo, P; Fels, A; Franzoni, E; Grosso, S; Habetswallner, F; Mangano, S; Parisi, P; Pascotto, A; Spalice, A; Veggiotti, P; Verrotti, A; Zamponi, N, 2010)
" A 13-year-old girl with genetically confirmed Pitt-Hopkins syndrome with uncontrolled seizures, while on treatment with levetiracetam and valproic acid, was started on perampanel, reaching seizure control."7.91Perampanel-induced hair curling in a patient with epilepsy associated with Pitt Hopkins syndrome. ( Calle-Lopez, Y; Knight, EP; Kotagal, P, 2019)
"Stiripentol is an antiepileptic drug (AED) approved by the European Medicines Agency for the treatment of Dravet Syndrome (DS) as adjunct treatment with valproate and clobazam."7.81Extending the use of stiripentol to other epileptic syndromes: a case of PCDH19-related epilepsy. ( Specchio, N; Trivisano, M; Vigevano, F, 2015)
"Two months-old girl with psychomotor retardation had aminophylline-resistant apnea attacks and was investigated by video-EEG recording."7.72[A case of infantile epileptic apnea with congenital brain anomaly]. ( Hamano, K; Iwasaki, N; Matsui, A; Ohto, T; Takahashi, M; Tanaka, R, 2003)
"Acute pancreatitis is rarely seen in children, and it is often drug induced."5.35Acute hemorrhagic pancreatitis due to the use of valproic acid in a child. ( Köse, G; Ozaydin, E; Yükselgüngör, H, 2008)
"This is the first multicenter Italian experience with rufinamide as an adjunctive drug in children, adolescents and adults with Lennox-Gastaut syndrome."5.14Rufinamide in children and adults with Lennox-Gastaut syndrome: first Italian multicenter experience. ( Balestri, A; Capovilla, G; Coppola, G; Curatolo, P; Fels, A; Franzoni, E; Grosso, S; Habetswallner, F; Mangano, S; Parisi, P; Pascotto, A; Spalice, A; Veggiotti, P; Verrotti, A; Zamponi, N, 2010)
"Under the medicine treatment of magnesium valproate with carbamazepine, the patient experienced partial seizures approximately once per month that lasted 30 to 60 seconds each without any complications observed during a follow-up period of 24 months."5.01A potential cause of adolescent onset Dyke-Davidoff-Masson syndrome: A case report. ( Jiang, Z; Li, B; Li, J; Li, Y; Wang, L; Zhang, T, 2019)
" A 13-year-old girl with genetically confirmed Pitt-Hopkins syndrome with uncontrolled seizures, while on treatment with levetiracetam and valproic acid, was started on perampanel, reaching seizure control."3.91Perampanel-induced hair curling in a patient with epilepsy associated with Pitt Hopkins syndrome. ( Calle-Lopez, Y; Knight, EP; Kotagal, P, 2019)
" Seizures were controlled in a few weeks with intramuscular synthetic ACTH, followed by valproic acid."3.81LAMA2-related congenital muscular dystrophy complicated by West syndrome. ( Camacho, A; de Aragón, AM; Dekomien, G; Hernández-Laín, A; Núñez, N; Simón, R, 2015)
"Stiripentol is an antiepileptic drug (AED) approved by the European Medicines Agency for the treatment of Dravet Syndrome (DS) as adjunct treatment with valproate and clobazam."3.81Extending the use of stiripentol to other epileptic syndromes: a case of PCDH19-related epilepsy. ( Specchio, N; Trivisano, M; Vigevano, F, 2015)
"Rufinamide (RUF) is an orphan drug for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome in persons aged 4 years and older."3.77Serum concentrations of rufinamide in children and adults with epilepsy: the influence of dose, age, and comedication. ( Boor, R; Brandt, C; Jürgens, U; Korn-Merker, E; May, TW; Rambeck, B, 2011)
"To investigate the effect of antiepileptic drugs, especially carbamazepine and valproate, on intelligence in prenatally exposed children of mothers with epilepsy."3.72Normal intelligence in children with prenatal exposure to carbamazepine. ( Bardy, A; Gaily, E; Granström, ML; Hiilesmaa, V; Isoaho, M; Kaaja, E; Kantola-Sorsa, E; Kotila, M; Matila, R; Nylund, T, 2004)
"Two months-old girl with psychomotor retardation had aminophylline-resistant apnea attacks and was investigated by video-EEG recording."3.72[A case of infantile epileptic apnea with congenital brain anomaly]. ( Hamano, K; Iwasaki, N; Matsui, A; Ohto, T; Takahashi, M; Tanaka, R, 2003)
" Following treatment with antiepileptic drugs (AEDs), the patient developed several rare complications: after beginning therapy with phenytoin, the patient developed pseudolymphoma; after monotherapy with carbamazepine (CBZ), the patient thereafter developed myoclonic jerks of upper and lower limbs upon awakening; after one year of treatment with valproate (VPA) the patient developed clinical and immuno-haematological signs of SLE."3.69Clinical case report: multiple idiosyncratic adverse effects of antiepileptic drugs in trisomy 9p. ( Diomedi, M; Gigli, GL; Masala, C; Placidi, F; Pomponi, MG; Scalise, A; Silvestri, G, 1996)
"A case of rapid cycling bipolar disorder in a person with Down's syndrome, responsive to divalproex sodium, a valproic acid derivative, is presented."3.68Divalproex-responsive rapid cycling bipolar disorder in a patient with Down's syndrome: implications for the Down's syndrome-mania hypothesis. ( Sovner, R, 1991)
"The case of a mentally handicapped female patient is presented who developed typical pellagra with dermatitis, diarrhoea and mental alteration following a long-term antiepileptic treatment with phenytoin, ethosuximide and valproic acid."3.68[Pellagra in anticonvulsive therapy]. ( Bartels, H; Hebestreit, H; Mingers, AM; Pannenbecker, J, 1990)
"Blood levels and seizures were monitored."2.68Effects of switching from Depakene to generic valproic acid on individuals with mental retardation. ( Kraushaar, KW; Vadney, VJ, 1997)
"Developmental retardation (speech, motor or global) was almost always present in children exposed to valproic acid."2.61Recent advances in trigonocephaly. ( Aillet, S; Mocquard, C; Riffaud, L, 2019)
"In patients with EAST syndrome, seizure is the first symptom occurring around 3-4 months of age."2.61Epilepsy in patients with EAST syndrome caused by mutation in the KCNJ10. ( Albaradie, R; Alhazmi, R; Alkhaldi, H; Chaudhary, M; Housawi, Y; Mir, A, 2019)
"For patients with migraine, the pregnancy labeling of VPA will be changed from Category "D" to "X."2.50Risks of neurobehavioral teratogenicity associated with prenatal exposure to valproate monotherapy: a systematic review with regulatory repercussions. ( Gentile, S, 2014)
"Full seizure control in the pre-pregnancy year, and adjusting antiepileptic drug doses to maintain plasma drug concentrations throughout pregnancy at values associated with seizure control before pregnancy, have major influences in preserving seizure control during pregnancy."2.50Treating epilepsy in pregnant women. ( Eadie, MJ, 2014)
" They responded well to the reduction in dosage or to withdrawal of the apparent causing agent."2.49[Medication-related oculogyric crises: a description of four cases and a review of the literature]. ( Campistol, J; Darling, A; Perez-Duenas, B; Poo, P, 2013)
"Epilepsy was controlled with valproate at the age of 6 years."2.42A study of EEG and epilepsy profile in Wolf-Hirschhorn syndrome and considerations regarding its correlation with other chromosomal disorders. ( Fiore, LA; Freitas, A; Kim, CA; Valente, KD, 2003)
"Over two-thirds of women/girls with intellectual disability (ID) may have treatment-resistant epilepsy that could benefit from VPA treatment."1.62Valproate prescribing practices for women with intellectual disability across Europe. ( Angus-Leppan, H; Banks, R; Courtenay, K; Murphy, E; Perera, B; Reuber, M; Shankar, R; Watkins, L, 2021)
"To study the risk of intellectual disability and delayed development in childhood milestones among children of women who used valproate or other AEDs during pregnancy."1.56Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs With Intellectual Disability and Delayed Childhood Milestones. ( Christensen, J; Daugaard, CA; Dreier, JW; Pedersen, L; Sun, Y, 2020)
"However, seizures are not typical and the majority of them were seizure-free."1.51A 16q22.2-q23.1 deletion identified in a male infant with West syndrome. ( Goji, A; Imoto, I; Ito, H; Kagami, S; Kohmoto, T; Mori, K; Mori, T; Toda, Y, 2019)
"The intractable seizures showed complete but transient responsiveness to pyridoxal phosphate and finally controlled by valproate treatment."1.51ARX-associated infantile epileptic-dyskinetic encephalopathy with responsiveness to valproate for controlling seizures and reduced activity of muscle mitochondrial complex IV. ( Chu, VL; Fung, CW; Kwong, AK; Rodenburg, RJT; Smeitink, J, 2019)
"Ataxia was observed in 7/34 cases."1.48Defining the phenotypic spectrum of SLC6A1 mutations. ( Abi-Warde, MT; Afenjar, A; Bird, LM; Carvill, GL; Chae, JH; Chelly, J; Choi, M; Christensen, J; Courage, C; Czapansky-Beilman, D; de Saint Martin, A; Devinsky, O; Doummar, D; Dubbs, H; Gardella, E; Gleeson, JG; Helbig, I; Helbig, KL; Hopkins, S; Johannesen, KM; Keren, B; Lehesjoki, AE; Lesca, G; Linnankivi, T; Mecarelli, O; Mefford, HC; Merritt, JL; Mignot, C; Millichap, JJ; Myers, CT; Møller, RS; Nava, C; Nespeca, M; Pal, DK; Pendziwiat, M; Pisani, L; Piton, A; Reichert, SC; Rodan, LH; Rubboli, G; Schaefer, E; Schelhaas, HJ; Shaw, JE; Specchio, N; Striano, P; Tan, WH; Tang, S; Trivisano, M; Verhoeven, JS; Weber, YG; Yoo, Y, 2018)
"Epilepsy is common in individuals with autism spectrum disorder (ASD) and intellectual disabilities (ID)."1.42Impact of epilepsy and antiepileptic medications on the metabolic profile in adults with autism spectrum disorder and intellectual disabilities. ( Katz, N; Moses, L; Weizman, A, 2015)
"For patients with mental retardation or developmental delay, 25(OH)D3 levels were lower than the levels in patients with normal intelligence quotient levels (p=0."1.40Vitamin D levels in children and adolescents with antiepileptic drug treatment. ( Baek, JH; Eun, BL; Kim, GH; Kim, MK; Seo, YH, 2014)
"Focal seizures were more frequent during drowsiness and sleep."1.39Epilepsy in Mowat-Wilson syndrome: delineation of the electroclinical phenotype. ( Bianchi, P; Bonetti, S; Boni, A; Buoni, S; Cecconi, I; Cerruti Mainardi, P; Cordelli, DM; Della Giustina, E; Doz, M; Epifanio, R; Faravelli, F; Ferrari, AR; Franzoni, E; Garavelli, L; Gelmini, C; Giordano, L; Grasso, M; Grioni, D; Grosso, S; Guerra, A; Licata, F; Malbora, B; Mammi, I; Mari, F; Mazzanti, L; Mostardini, R; Pantaleoni, C; Pellicciari, A; Poch-Olivé, ML; Rivieri, F; Rosato, S; Savasta, S; Seri, M; Simonte, G; Sorge, G; Tarani, L; Terazzi, E; Wischmeijer, A; Zanotta, N; Zollino, M, 2013)
"Propofol was infused, and sedation was maintained at the same level in all patients using a bispectral index (BIS) monitor."1.38The influence of oral VPA on the required dose of propofol for sedation during dental treatment in patients with mental retardation: a prospective observer-blinded cohort study. ( Egusa, M; Higuchi, H; Ishii, M; Maeda, S; Miyawaki, T; Tomoyasu, Y, 2012)
"The prevalence of unrecognized primary hypothyroidism and hyperthyroidism was 5·2% and 2·8%, respectively."1.37Thyroid status in a large cohort of patients with mental retardation: the TOP-R (Thyroid Origin of Psychomotor Retardation) study. ( de Rijke, YB; van Toor, H; Visser, TJ; Visser, WE, 2011)
"On VPA 1000 mg/d, the seizure frequency decreased significantly."1.37Valproate treatment after liver transplant in a patient with Lennox-Gastaut syndrome. ( Crespel, A; Gelisse, P; Genton, P; Pageaux, GP; Velizarova, R, 2011)
"Epilepsy is one of the most frequent neurological diseases in the pediatric population."1.36[Characteristics of the children with epilepsy followed in the Marrakech University Hospital]. ( Amine, M; Bourrous, M; Bouskraoui, M; Draiss, G; Elibrahimi, I; Safini, F, 2010)
"This article describes a girl with mental retardation, probably due to a perinatal complication, who had typical absence seizures with characteristic electroencephalographic findings of childhood absence epilepsy, including normal background activity."1.35Childhood absence epilepsy with clinically apparent genetic and acquired burdens: a diagnostic consideration. ( Wakamoto, H, 2008)
"Minor motor seizures from the 10th month onwards are successfully treated with Valproate."1.35Prenatal diagnosis of cerebral lesions in Tuberous sclerosis complex (TSC). Case report and review of the literature. ( Creemers, JW; Mullaart, RA; Reimer, A; Wortmann, SB, 2008)
"Acute pancreatitis is rarely seen in children, and it is often drug induced."1.35Acute hemorrhagic pancreatitis due to the use of valproic acid in a child. ( Köse, G; Ozaydin, E; Yükselgüngör, H, 2008)
"Epilepsy is often the most important clinical manifestation of the syndrome, even if its appearance is not constantly precocious."1.35Ring chromosome 20 syndrome: a link between epilepsy onset and neuropsychological impairment in three children. ( Canevini, MP; Dalla Bernardina, B; Darra, F; Fiorini, E; La Selva, L; Lazzarotto, F; Piazzini, A; Vignoli, A; Zucca, C, 2009)
"A 25-year-old girl with mild mental retardation had a 6-year history of absence seizures, with occasional head drop."1.31Mild generalized epilepsy and developmental disorder associated with large inv dup(15). ( Canevini, MP; Canger, R; Cavani, S; Chifari, R; Elia, M; Guerrini, R; Pierluigi, M; Sgrò, V, 2002)
" Reduction of VPA dosage and subsequent discontinuation 4 months later resulted in disappearance of clinical symptoms with a 20-point improvement at IQ testing and recovery of previous PM score."1.30Reversible pseudoatrophy of the brain and mental deterioration associated with valproate treatment. ( Belmonte, A; Canapicchi, R; Casalini, C; Guerrini, R; Perucca, E, 1998)
"Mental retardation is present only in patients with poor seizure control."1.30Epilepsy with myoclonic absences with early onset: a follow-up study. ( Chiarelli, F; Domizio, S; Greco, R; Morgese, G; Sabatino, G; Verrotti, A, 1999)
" VPA dosage was tapered and discontinued, with accompanying resolution of clinical, immunological and hematological signs of SLE 6 weeks after VPA discontinuation."1.29Valproate-induced systemic lupus erythematosus in a patient with partial trisomy of chromosome 9 and epilepsy. ( Diomedi, M; Gigli, GL; Grazia Pomponi, M; Masala, C; Pauri, F; Placidi, F; Scalise, A; Silvestri, G, 1996)
"Pancreatitis is usually considered a rare side effect of valproate."1.29Valproate-associated pancreatitis and cholecystitis in six mentally retarded adults. ( Buzan, RD; Dubovsky, SL; Firestone, D; Thomas, M, 1995)
"The case of an adolescent with severe mental retardation, blindness, and a complex of behavioral symptoms consistent with mania is reported."1.28Verapamil and valproic acid treatment of prolonged mania. ( Friedman, DL; Kastner, T, 1992)
"In contrast, cryptogenic infantile spasms, in which there is no identifiable brain lesion, usually run a favorable course under treatment."1.28[A prognostic study of cryptogenic infantile spasms]. ( Boulloche, J; Dautreme, P; Le Luyer, B; Mallet, E; Tron, P, 1991)

Research

Studies (86)

TimeframeStudies, this research(%)All Research%
pre-19904 (4.65)18.7374
1990's23 (26.74)18.2507
2000's18 (20.93)29.6817
2010's29 (33.72)24.3611
2020's12 (13.95)2.80

Authors

AuthorsStudies
Lhamu, T1
Sadh, K1
Dahale, AB1
Mohan, V1
Loganathan, S1
Bjørk, MH1
Zoega, H1
Leinonen, MK1
Cohen, JM1
Dreier, JW2
Furu, K1
Gilhus, NE1
Gissler, M1
Hálfdánarson, Ó1
Igland, J1
Sun, Y2
Tomson, T1
Alvestad, S1
Christensen, J3
Ju, Y1
Ji, TY1
Kessi, M1
Chen, B2
Shan, LD1
Wang, Y1
Yang, L2
Yin, F1
He, F1
Peng, J2
Wang, G1
Wang, XL1
Tian, YN1
Chen, C1
Hofmeister, B2
von Stülpnagel, C2
Berweck, S2
Abicht, A1
Kluger, G2
Weber, P2
Mocquard, C1
Aillet, S1
Riffaud, L1
Calle-Lopez, Y1
Kotagal, P1
Knight, EP1
Li, Y1
Zhang, T1
Li, B1
Li, J1
Wang, L1
Jiang, Z1
Finsterer, J2
Devries, S1
Mulder, M1
Charron, JG1
Prokop, JW1
Mark, PR1
Watkins, L1
Reuber, M1
Perera, B1
Courtenay, K1
Banks, R1
Murphy, E1
Angus-Leppan, H1
Shankar, R1
Daugaard, CA1
Pedersen, L1
Kang, Q1
Liao, H1
Wu, L1
Yang, S1
Kuang, X1
Yang, H1
Liao, C1
Johannesen, KM1
Gardella, E1
Linnankivi, T1
Courage, C1
de Saint Martin, A1
Lehesjoki, AE1
Mignot, C1
Afenjar, A1
Lesca, G1
Abi-Warde, MT1
Chelly, J1
Piton, A1
Merritt, JL1
Rodan, LH1
Tan, WH1
Bird, LM1
Nespeca, M1
Gleeson, JG1
Yoo, Y1
Choi, M1
Chae, JH1
Czapansky-Beilman, D1
Reichert, SC1
Pendziwiat, M1
Verhoeven, JS1
Schelhaas, HJ1
Devinsky, O1
Specchio, N2
Trivisano, M2
Weber, YG1
Nava, C1
Keren, B1
Doummar, D1
Schaefer, E1
Hopkins, S1
Dubbs, H1
Shaw, JE1
Pisani, L1
Myers, CT1
Tang, S2
Pal, DK1
Millichap, JJ1
Carvill, GL1
Helbig, KL1
Mecarelli, O1
Striano, P1
Helbig, I1
Rubboli, G1
Mefford, HC1
Møller, RS1
Ono, H1
Arora, V1
Joshi, A1
Lall, M1
Agarwal, S1
Bijarnia Mahay, S1
Dua Puri, R1
Chander Verma, I1
Mir, A1
Chaudhary, M1
Alkhaldi, H1
Alhazmi, R1
Albaradie, R1
Housawi, Y1
Clayton-Smith, J1
Bromley, R1
Dean, J1
Journel, H1
Odent, S1
Wood, A1
Williams, J1
Cuthbert, V1
Hackett, L1
Aslam, N1
Malm, H1
James, G1
Westbom, L1
Day, R1
Ladusans, E1
Jackson, A1
Bruce, I1
Walker, R1
Sidhu, S1
Dyer, C1
Ashworth, J1
Hindley, D1
Diaz, GA1
Rawson, M1
Turnpenny, P1
Kwong, AK1
Chu, VL1
Rodenburg, RJT1
Smeitink, J1
Fung, CW1
Mori, T1
Goji, A1
Toda, Y1
Ito, H1
Mori, K1
Kohmoto, T1
Imoto, I1
Kagami, S1
Ennaim, N1
Bourrous, M2
Rada, N1
Draiss, G2
Bouskraoui, M2
Baek, JH1
Seo, YH1
Kim, GH1
Kim, MK1
Eun, BL1
Gentile, S1
Eadie, MJ1
Camacho, A1
Núñez, N1
Dekomien, G1
Hernández-Laín, A1
de Aragón, AM1
Simón, R1
Vigevano, F1
Maeda, S2
Tomoyasu, Y2
Higuchi, H2
Ishii-Maruhama, M1
Egusa, M2
Miyawaki, T2
Moses, L1
Katz, N1
Weizman, A1
Vignoli, A1
Canevini, MP2
Darra, F1
La Selva, L1
Fiorini, E1
Piazzini, A1
Lazzarotto, F1
Zucca, C1
Dalla Bernardina, B1
Hellings, JA1
Barth, FX1
Logan, M1
Cook-Wiens, G1
Osorio, I1
Reed, RC1
Elibrahimi, I1
Safini, F1
Amine, M1
Coppola, G1
Grosso, S2
Franzoni, E2
Veggiotti, P1
Zamponi, N1
Parisi, P1
Spalice, A1
Habetswallner, F1
Fels, A1
Capovilla, G1
Verrotti, A2
Mangano, S1
Balestri, A1
Curatolo, P1
Pascotto, A1
Chen, K1
Mi, YJ1
Ma, Y1
Fu, HL1
Jin, WL1
Velizarova, R1
Gelisse, P1
Pageaux, GP1
Genton, P2
Crespel, A1
May, TW1
Boor, R1
Rambeck, B1
Jürgens, U1
Korn-Merker, E1
Brandt, C1
Visser, WE1
de Rijke, YB1
van Toor, H1
Visser, TJ1
Ishii, M1
Brownstone, E1
Voigtländer, T1
Baumhackl, U1
Cordelli, DM1
Garavelli, L1
Savasta, S1
Guerra, A1
Pellicciari, A1
Giordano, L1
Bonetti, S1
Cecconi, I1
Wischmeijer, A1
Seri, M1
Rosato, S1
Gelmini, C1
Della Giustina, E1
Ferrari, AR1
Zanotta, N1
Epifanio, R1
Grioni, D1
Malbora, B1
Mammi, I1
Mari, F1
Buoni, S1
Mostardini, R1
Pantaleoni, C1
Doz, M1
Poch-Olivé, ML1
Rivieri, F1
Sorge, G1
Simonte, G1
Licata, F1
Tarani, L1
Terazzi, E1
Mazzanti, L1
Cerruti Mainardi, P1
Boni, A1
Faravelli, F1
Grasso, M1
Bianchi, P1
Zollino, M1
Darling, A1
Poo, P1
Perez-Duenas, B1
Campistol, J1
Chifari, R1
Guerrini, R2
Pierluigi, M1
Cavani, S1
Sgrò, V1
Elia, M1
Canger, R1
Olson, DA1
Ingram, W1
Mann, JR1
Audic-Gerard, F1
Szepetowski, P1
Valente, KD1
Freitas, A1
Fiore, LA1
Kim, CA1
Ohto, T1
Iwasaki, N1
Takahashi, M1
Tanaka, R1
Hamano, K1
Matsui, A1
Gaily, E1
Kantola-Sorsa, E1
Hiilesmaa, V1
Isoaho, M1
Matila, R1
Kotila, M1
Nylund, T1
Bardy, A1
Kaaja, E1
Granström, ML1
Yoshikawa, H1
Dhanaraj, M1
Jayavelu, A1
Vinten, J1
Adab, N1
Kini, U1
Gorry, J1
Gregg, J1
Baker, GA1
Wagner, GC1
Reuhl, KR1
Cheh, M1
McRae, P1
Halladay, AK1
Schmitz, B1
Krämer, G1
Helmstädter, C1
Jokeit, H1
Koch, S1
Luef, G1
Schaefer, C1
Vorbrodt, AW1
Dobrogowska, DH1
Kozlowski, PB1
Rabe, A1
Tarnawski, M1
Lee, MH1
Duncan, S1
Wortmann, SB1
Reimer, A1
Creemers, JW1
Mullaart, RA1
Ozaydin, E1
Yükselgüngör, H1
Köse, G1
Wakamoto, H1
Williams, CA1
Tiefenbach, S1
McReynolds, JW1
Buzan, RD1
Firestone, D1
Thomas, M1
Dubovsky, SL1
Feldstein, JH1
Curtis, JL1
Kastner, T3
Finesmith, R1
Walsh, K1
Whittier, MC1
West, SA1
Galli, VB1
Raute, NJ1
Gigli, GL2
Scalise, A2
Pauri, F1
Silvestri, G2
Diomedi, M2
Placidi, F2
Grazia Pomponi, M1
Masala, C2
Sovner, R4
Stone, A1
Fox, C1
Pomponi, MG1
Brasić, JR1
Barnett, JY1
Cranor, CW1
Sawyer, WT1
Carson, SW1
Early, JJ1
Vadney, VJ1
Kraushaar, KW1
Belmonte, A1
Canapicchi, R1
Casalini, C1
Perucca, E1
Alvarez, N1
Williams, R1
Friis, ML1
Ruedrich, S1
Swales, TP1
Fossaceca, C1
Toliver, J1
Rutkowski, A1
Vanstraelen, M1
Tyrer, SP1
Greco, R1
Chiarelli, F1
Domizio, S1
Sabatino, G1
Morgese, G1
Mattes, JA1
Friedman, DL2
Boulloche, J1
Dautreme, P1
Le Luyer, B1
Mallet, E1
Tron, P1
Davis, JM1
Hebestreit, H1
Pannenbecker, J1
Mingers, AM1
Bartels, H1
Plummer, AT1
Ruiz, MQ1
Henning, D1
Matsuda, I1
Ohtani, Y1
Ninomiya, N1
Sheppard, LC1
Ballinger, BR1
Fenton, GW1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
PSG in Valproate-induced Nocturnal Enuresis in Children[NCT04191863]260 participants (Actual)Observational2018-09-01Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

13 reviews available for valproic acid and Deficiency, Mental

ArticleYear
[Autosomal dominant mental retardation type 5 caused by
    Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 2023, May-15, Volume: 25, Issue:5

    Topics: Child; Codon, Nonsense; Humans; Intellectual Disability; Mutation; ras GTPase-Activating Proteins; R

2023
Recent advances in trigonocephaly.
    Neuro-Chirurgie, 2019, Volume: 65, Issue:5

    Topics: Anticonvulsants; Child; Child, Preschool; Craniosynostoses; Humans; Infant; Infant, Newborn; Intelle

2019
A potential cause of adolescent onset Dyke-Davidoff-Masson syndrome: A case report.
    Medicine, 2019, Volume: 98, Issue:51

    Topics: Brain Diseases; Carbamazepine; China; Chronic Disease; Female; Humans; Intellectual Disability; Magn

2019
Epilepsy in patients with EAST syndrome caused by mutation in the KCNJ10.
    Brain & development, 2019, Volume: 41, Issue:8

    Topics: Anticonvulsants; Brain; Carbamazepine; Cerebellar Ataxia; Child; Child, Preschool; Epilepsy; Female;

2019
Risks of neurobehavioral teratogenicity associated with prenatal exposure to valproate monotherapy: a systematic review with regulatory repercussions.
    CNS spectrums, 2014, Volume: 19, Issue:4

    Topics: Anticonvulsants; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Bipolar Di

2014
Treating epilepsy in pregnant women.
    Expert opinion on pharmacotherapy, 2014, Volume: 15, Issue:6

    Topics: Anticonvulsants; Congenital Abnormalities; Epilepsy; Female; Humans; Intellectual Disability; Matern

2014
[Medication-related oculogyric crises: a description of four cases and a review of the literature].
    Revista de neurologia, 2013, Feb-01, Volume: 56, Issue:3

    Topics: Adolescent; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Child; Child Behavior Disorders; Ch

2013
A study of EEG and epilepsy profile in Wolf-Hirschhorn syndrome and considerations regarding its correlation with other chromosomal disorders.
    Brain & development, 2003, Volume: 25, Issue:4

    Topics: Angelman Syndrome; Anticonvulsants; Child; Chromosome Deletion; Chromosome Disorders; Chromosomes, H

2003
[Neuropsychological outcome following intrauterine exposure to valproate].
    Der Nervenarzt, 2006, Volume: 77, Issue:8

    Topics: Female; Germany; Humans; Intellectual Disability; Mental Disorders; Practice Guidelines as Topic; Pr

2006
Teratogenesis of sodium valproate.
    Current opinion in neurology, 2007, Volume: 20, Issue:2

    Topics: Anticonvulsants; Developmental Disabilities; Epilepsy; Female; Humans; Infant, Newborn; Intellectual

2007
Ring chromosome 22 and mood disorders.
    Journal of intellectual disability research : JIDR, 1996, Volume: 40 ( Pt 1)

    Topics: Adult; Anticonvulsants; Antidepressive Agents; Child; Chromosomes, Human, Pair 22; Drug Therapy, Com

1996
Valproate in the treatment of epilepsy in people with intellectual disability.
    Journal of intellectual disability research : JIDR, 1998, Volume: 42 Suppl 1

    Topics: Anticonvulsants; Epilepsy; Humans; Intellectual Disability; Treatment Outcome; Valproic Acid

1998
Rapid cycling bipolar affective disorder in people with intellectual disability: a systematic review.
    Journal of intellectual disability research : JIDR, 1999, Volume: 43 ( Pt 5)

    Topics: Antimanic Agents; Bipolar Disorder; Carbamazepine; Down Syndrome; Humans; Intellectual Disability; L

1999

Trials

5 trials available for valproic acid and Deficiency, Mental

ArticleYear
Overnight versus progressive conversion of multiple daily-dose divalproex to once-daily divalproex extended release: which strategy is better tolerated by adults with intellectual disabilities?
    Journal of clinical psychopharmacology, 2009, Volume: 29, Issue:5

    Topics: Adult; Delayed-Action Preparations; Drug Administration Schedule; Female; Humans; Intellectual Disab

2009
Rufinamide in children and adults with Lennox-Gastaut syndrome: first Italian multicenter experience.
    Seizure, 2010, Volume: 19, Issue:9

    Topics: Adolescent; Adult; Anticonvulsants; Child; Child, Preschool; Drug Therapy, Combination; Female; Huma

2010
Long-term administration of valproic acid in the treatment of affective symptoms in people with mental retardation.
    Journal of clinical psychopharmacology, 1993, Volume: 13, Issue:6

    Topics: Adolescent; Adult; Child; Epilepsy; Female; Humans; Intellectual Disability; Male; Mood Disorders; P

1993
Effects of switching from Depakene to generic valproic acid on individuals with mental retardation.
    Mental retardation, 1997, Volume: 35, Issue:6

    Topics: Adolescent; Adult; Aged; Anticonvulsants; Cross-Over Studies; Drugs, Generic; Humans; Intellectual D

1997
Effect of divalproex sodium on aggression and self-injurious behaviour in adults with intellectual disability: a retrospective review.
    Journal of intellectual disability research : JIDR, 1999, Volume: 43 ( Pt 2)

    Topics: Adult; Aggression; Female; GABA Agents; Humans; Intellectual Disability; Male; Middle Aged; Retrospe

1999

Other Studies

68 other studies available for valproic acid and Deficiency, Mental

ArticleYear
Valproate-Induced Pancytopenia and Phenytoin Toxicity in a Young Adult With Intellectual Disability and Mesial Temporal Lobe Sclerosis.
    The primary care companion for CNS disorders, 2021, Dec-23, Volume: 23, Issue:6

    Topics: Humans; Intellectual Disability; Pancytopenia; Phenytoin; Sclerosis; Temporal Lobe; Valproic Acid; Y

2021
Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability.
    JAMA neurology, 2022, 07-01, Volume: 79, Issue:7

    Topics: Anticonvulsants; Autism Spectrum Disorder; Autistic Disorder; Carbamazepine; Child; Cohort Studies;

2022
[Clinical features of epilepsy in 5 children with Mowat-Wilson syndrome].
    Zhonghua er ke za zhi = Chinese journal of pediatrics, 2022, Jun-02, Volume: 60, Issue:6

    Topics: Child; Electroencephalography; Epilepsy; Facies; Female; Hirschsprung Disease; Humans; Intellectual

2022
Genotype-phenotype correlations of STXBP1 pathogenic variants and the treatment choices for STXBP1-related disorders in China.
    BMC medical genomics, 2023, 03-07, Volume: 16, Issue:1

    Topics: Adrenocorticotropic Hormone; China; Female; Genetic Association Studies; Humans; Intellectual Disabi

2023
Cooccurrence of Two Different Genetic Diseases: A Case of Valproic Acid Hepatotoxicity in Nicolaides-Baraitser Syndrome (SMARCA2 Mutation)-Due to a POLG1-Related Effect?
    Neuropediatrics, 2020, Volume: 51, Issue:1

    Topics: Anticonvulsants; Chemical and Drug Induced Liver Injury; Child; DNA Polymerase gamma; Facies; Female

2020
Perampanel-induced hair curling in a patient with epilepsy associated with Pitt Hopkins syndrome.
    Epileptic disorders : international epilepsy journal with videotape, 2019, Oct-01, Volume: 21, Issue:5

    Topics: Adolescent; Anticonvulsants; Epilepsy; Facies; Female; Hair; Humans; Hyperventilation; Intellectual

2019
Overlapping Phenotype from Double Trouble SMARCA2 and POLG1 Variants c.2556A > C and c.3708G > T, Respectively.
    Neuropediatrics, 2020, Volume: 51, Issue:3

    Topics: Chemical and Drug Induced Liver Injury; Facies; Foot Deformities, Congenital; Humans; Hypotrichosis;

2020
Response To: Overlapping Phenotype from Double Trouble SMARCA2 and POLG1 Variants c.2556A > C and c.3708G > T, Respectively.
    Neuropediatrics, 2020, Volume: 51, Issue:5

    Topics: Chemical and Drug Induced Liver Injury; Facies; Foot Deformities, Congenital; Humans; Hypotrichosis;

2020
SLC6A1 G443D associated with developmental delay and epilepsy.
    Cold Spring Harbor molecular case studies, 2020, Volume: 6, Issue:4

    Topics: Child, Preschool; Developmental Disabilities; Epilepsy; Female; GABA Plasma Membrane Transport Prote

2020
Valproate prescribing practices for women with intellectual disability across Europe.
    Acta neurologica Scandinavica, 2021, Volume: 143, Issue:1

    Topics: Adolescent; Adult; Anticonvulsants; Drug Prescriptions; Epilepsy; Europe; Female; Humans; Intellectu

2021
Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs With Intellectual Disability and Delayed Childhood Milestones.
    JAMA network open, 2020, 11-02, Volume: 3, Issue:11

    Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Clonazepam; Denmark; Developmen

2020
CNKSR2 gene mutation leads to Houge type of X-linked syndromic mental retardation: A case report and review of literature.
    Medicine, 2021, Jun-11, Volume: 100, Issue:23

    Topics: Adaptor Proteins, Signal Transducing; Anticonvulsants; Child; Codon, Nonsense; Epilepsy; Humans; Int

2021
Defining the phenotypic spectrum of SLC6A1 mutations.
    Epilepsia, 2018, Volume: 59, Issue:2

    Topics: Adolescent; Adult; Anticonvulsants; Ataxia; Child; Child, Preschool; Cohort Studies; Electroencephal

2018
Sodium valproate-induced Fanconi syndrome in two severely disabled patients receiving carnitine supplementation.
    Clinical and experimental nephrology, 2019, Volume: 23, Issue:1

    Topics: Adult; Anticonvulsants; Carnitine; Disabled Persons; Epilepsy; Fanconi Syndrome; Female; Humans; Int

2019
Fetal valproate syndrome as a phenocopy of Kleefstra syndrome.
    Birth defects research, 2018, 09-01, Volume: 110, Issue:15

    Topics: Abnormalities, Drug-Induced; Adult; Child, Preschool; Chromosome Deletion; Chromosomes, Human, Pair

2018
Diagnosis and management of individuals with Fetal Valproate Spectrum Disorder; a consensus statement from the European Reference Network for Congenital Malformations and Intellectual Disability.
    Orphanet journal of rare diseases, 2019, 07-19, Volume: 14, Issue:1

    Topics: Anticonvulsants; Consensus; Female; Humans; Intellectual Disability; Pregnancy; Pregnancy Complicati

2019
ARX-associated infantile epileptic-dyskinetic encephalopathy with responsiveness to valproate for controlling seizures and reduced activity of muscle mitochondrial complex IV.
    Brain & development, 2019, Volume: 41, Issue:10

    Topics: Adolescent; Adult; Asian People; China; Cytochrome-c Oxidase Deficiency; Dystonic Disorders; Epileps

2019
A 16q22.2-q23.1 deletion identified in a male infant with West syndrome.
    Brain & development, 2019, Volume: 41, Issue:10

    Topics: Anticonvulsants; Chromosomes, Human, Pair 16; Epilepsy; Humans; Infant; Intellectual Disability; Lam

2019
[Lennox-Gastaut syndrome: Experience of Marrakech University Hospital].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2013, Volume: 20, Issue:10

    Topics: Accidental Falls; Anticonvulsants; Asphyxia Neonatorum; Atrophy; Cerebral Cortex; Child; Child, Pres

2013
[Valproic acid during pregnancy lowers IQ in children].
    Versicherungsmedizin, 2013, Sep-01, Volume: 65, Issue:3

    Topics: Anticonvulsants; Epilepsy; Female; Humans; Intellectual Disability; Maternal-Fetal Exchange; Nervous

2013
Vitamin D levels in children and adolescents with antiepileptic drug treatment.
    Yonsei medical journal, 2014, Volume: 55, Issue:2

    Topics: Adolescent; Anticonvulsants; Bone Density; Bone Diseases, Metabolic; Carbamazepine; Child; Child, Pr

2014
LAMA2-related congenital muscular dystrophy complicated by West syndrome.
    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 2015, Volume: 19, Issue:2

    Topics: Adrenocorticotropic Hormone; Anticonvulsants; Brain; Child, Preschool; Electroencephalography; Human

2015
Extending the use of stiripentol to other epileptic syndromes: a case of PCDH19-related epilepsy.
    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 2015, Volume: 19, Issue:2

    Topics: Age of Onset; Anticonvulsants; Autistic Disorder; Benzodiazepines; Cadherins; Child; Clobazam; Cogni

2015
Independent predictors of delay in emergence from general anesthesia.
    Anesthesia progress, 2015,Spring, Volume: 62, Issue:1

    Topics: Adult; Ambulatory Care; Anesthesia, Dental; Anesthesia, General; Anesthetics, Inhalation; Anesthetic

2015
Impact of epilepsy and antiepileptic medications on the metabolic profile in adults with autism spectrum disorder and intellectual disabilities.
    International clinical psychopharmacology, 2015, Volume: 30, Issue:6

    Topics: Adult; Anticonvulsants; Autism Spectrum Disorder; Blood Glucose; Body Mass Index; Carbamazepine; Cho

2015
Ring chromosome 20 syndrome: a link between epilepsy onset and neuropsychological impairment in three children.
    Epilepsia, 2009, Volume: 50, Issue:11

    Topics: Adult; Age of Onset; Anticonvulsants; Child; Chromosomes, Human, Pair 20; Cognition Disorders; Comor

2009
[Characteristics of the children with epilepsy followed in the Marrakech University Hospital].
    Revue neurologique, 2010, Volume: 166, Issue:11

    Topics: Adolescent; Age of Onset; Anticonvulsants; Cerebral Palsy; Child; Child, Preschool; Consanguinity; E

2010
The mental retardation associated protein, srGAP3 negatively regulates VPA-induced neuronal differentiation of Neuro2A cells.
    Cellular and molecular neurobiology, 2011, Volume: 31, Issue:5

    Topics: Animals; Antibodies; Antibody Specificity; Cell Differentiation; Cell Line, Tumor; Gene Knockdown Te

2011
Valproate treatment after liver transplant in a patient with Lennox-Gastaut syndrome.
    Seizure, 2011, Volume: 20, Issue:6

    Topics: Anticonvulsants; Chemical and Drug Induced Liver Injury; Electroencephalography; Female; Fructose; H

2011
Serum concentrations of rufinamide in children and adults with epilepsy: the influence of dose, age, and comedication.
    Therapeutic drug monitoring, 2011, Volume: 33, Issue:2

    Topics: Adolescent; Adult; Age Factors; Anticonvulsants; Body Weight; Child; Child, Preschool; Dose-Response

2011
Thyroid status in a large cohort of patients with mental retardation: the TOP-R (Thyroid Origin of Psychomotor Retardation) study.
    Clinical endocrinology, 2011, Volume: 75, Issue:3

    Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Cohort Studies; Cross-Sectional Studies; Drug Therapy,

2011
The influence of oral VPA on the required dose of propofol for sedation during dental treatment in patients with mental retardation: a prospective observer-blinded cohort study.
    Epilepsia, 2012, Volume: 53, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Anticonvulsants; Dental Care; Dose-Response Relationship, D

2012
Epilepsy in adult X-linked adrenoleucodystrophy due to the deletion c.1415-1416delAG in exon 5 of the ABCD1-gene.
    Gene, 2013, Jan-15, Volume: 513, Issue:1

    Topics: Adrenoleukodystrophy; Anticonvulsants; ATP Binding Cassette Transporter, Subfamily D, Member 1; ATP-

2013
Epilepsy in Mowat-Wilson syndrome: delineation of the electroclinical phenotype.
    American journal of medical genetics. Part A, 2013, Volume: 161A, Issue:2

    Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; DNA Mutational Analysis; Electroencephalograph

2013
Mild generalized epilepsy and developmental disorder associated with large inv dup(15).
    Epilepsia, 2002, Volume: 43, Issue:9

    Topics: Adult; Age of Onset; Angelman Syndrome; Anticonvulsants; Chromosome Aberrations; Chromosome Inversio

2002
Combination of olanzapine and divalproex for agitation in individuals with profound mental retardation.
    Journal of clinical psychopharmacology, 2002, Volume: 22, Issue:5

    Topics: Adult; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Female; H

2002
[GEFS + syndrome: phenotypic variations from the newborn to the adult in a large French pedigree].
    Revue neurologique, 2003, Volume: 159, Issue:2

    Topics: Adolescent; Adult; Anticonvulsants; Child; Child, Preschool; Electroencephalography; Epilepsy, Gener

2003
[A case of infantile epileptic apnea with congenital brain anomaly].
    No to hattatsu = Brain and development, 2003, Volume: 35, Issue:6

    Topics: Apnea; Brain; Electroencephalography; Epilepsy; Female; Humans; Infant; Intellectual Disability; Val

2003
Normal intelligence in children with prenatal exposure to carbamazepine.
    Neurology, 2004, Jan-13, Volume: 62, Issue:1

    Topics: Anticonvulsants; Carbamazepine; Child; Child, Preschool; Dose-Response Relationship, Drug; Epilepsy;

2004
The difficulties of diagnosing VPA-induced pancreatitis in children with severe motor and intellectual disabilities.
    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 2004, Volume: 8, Issue:2

    Topics: Acute Disease; Anticonvulsants; Child, Preschool; Epilepsy; Female; Humans; Intellectual Disability;

2004
Non-equivalence of bioavailability between generic and branded form of sodium valproate.
    Neurology India, 2004, Volume: 52, Issue:3

    Topics: Adult; Anticonvulsants; Biological Availability; Drugs, Generic; Epilepsy, Generalized; Humans; Inte

2004
Neuropsychological effects of exposure to anticonvulsant medication in utero.
    Neurology, 2005, Mar-22, Volume: 64, Issue:6

    Topics: Adolescent; Anticonvulsants; Brain; Child; Cognition Disorders; Cohort Studies; Epilepsy; Female; Hu

2005
A new neurobehavioral model of autism in mice: pre- and postnatal exposure to sodium valproate.
    Journal of autism and developmental disorders, 2006, Volume: 36, Issue:6

    Topics: Animals; Animals, Newborn; Anticonvulsants; Attention; Autistic Disorder; Disease Models, Animal; Do

2006
Immunogold study of effects of prenatal exposure to lipopolysaccharide and/or valproic acid on the rat blood-brain barrier vessels.
    Journal of neurocytology, 2005, Volume: 34, Issue:6

    Topics: Albumins; Animals; Blood-Brain Barrier; Brain Ischemia; Cell Membrane; Cerebral Arteries; Child; Dev

2005
Prenatal diagnosis of cerebral lesions in Tuberous sclerosis complex (TSC). Case report and review of the literature.
    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 2008, Volume: 12, Issue:2

    Topics: Adult; Anticonvulsants; Brain; Female; Genetic Counseling; Heart Neoplasms; Humans; Infant, Newborn;

2008
Acute hemorrhagic pancreatitis due to the use of valproic acid in a child.
    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 2008, Volume: 12, Issue:2

    Topics: Acute Disease; Anticonvulsants; Child; Epilepsy, Generalized; Hemorrhage; Humans; Intellectual Disab

2008
Childhood absence epilepsy with clinically apparent genetic and acquired burdens: a diagnostic consideration.
    Journal of child neurology, 2008, Volume: 23, Issue:1

    Topics: Action Potentials; Anticonvulsants; Birth Injuries; Brain; Causality; Child; Child, Preschool; Comor

2008
Valproic acid-induced hyperammonemia in mentally retarded adults.
    Neurology, 1984, Volume: 34, Issue:4

    Topics: Adolescent; Adult; Aged; Ammonia; Female; Humans; Intellectual Disability; Male; Middle Aged; Valpro

1984
Valproate-associated pancreatitis and cholecystitis in six mentally retarded adults.
    The Journal of clinical psychiatry, 1995, Volume: 56, Issue:11

    Topics: Adult; Anticonvulsants; Bipolar Disorder; Cholecystitis; Comorbidity; Epilepsy; Humans; Intellectual

1995
Update on the costs of Depakote and Depakene.
    Mental retardation, 1995, Volume: 33, Issue:1

    Topics: Cost Savings; Humans; Intellectual Disability; Seizures; Valproic Acid

1995
Valproic acid for dysphoric mania in a mentally retarded adolescent.
    The Journal of clinical psychiatry, 1995, Volume: 56, Issue:12

    Topics: Adolescent; Bipolar Disorder; Drug Administration Schedule; Female; Humans; Intellectual Disability;

1995
Valproate-induced systemic lupus erythematosus in a patient with partial trisomy of chromosome 9 and epilepsy.
    Epilepsia, 1996, Volume: 37, Issue:6

    Topics: Adult; Chromosomes, Human, Pair 9; Comorbidity; Epilepsy; Female; HLA-DR4 Antigen; Humans; Intellect

1996
Clinical case report: multiple idiosyncratic adverse effects of antiepileptic drugs in trisomy 9p.
    The International journal of neuroscience, 1996, Volume: 87, Issue:3-4

    Topics: Adult; Anticonvulsants; Brain; Carbamazepine; Chromosome Aberrations; Chromosome Disorders; Chromoso

1996
Hyperkinesias in a prepubertal boy with autistic disorder treated with haloperidol and valproic acid.
    Psychological reports, 1997, Volume: 80, Issue:1

    Topics: Anti-Dyskinesia Agents; Anticonvulsants; Attention Deficit Disorder with Hyperactivity; Autistic Dis

1997
Clinical and economic impact of replacing divalproex sodium with valproic acid.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1997, Aug-01, Volume: 54, Issue:15

    Topics: Adult; Anticonvulsants; Costs and Cost Analysis; Epilepsy; Female; Hospitals, Psychiatric; Humans; I

1997
Reversible pseudoatrophy of the brain and mental deterioration associated with valproate treatment.
    Epilepsia, 1998, Volume: 39, Issue:1

    Topics: Atrophy; Brain; Brain Diseases; Child; Cognition Disorders; Diagnosis, Differential; Electroencephal

1998
Comment on Vadney and Kraushaar's "Effect of switching from Depakene to generic valproic acid on individuals with mental retardation".
    Mental retardation, 1998, Volume: 36, Issue:4

    Topics: Anticonvulsants; Bipolar Disorder; Humans; Intellectual Disability; Valproic Acid

1998
Epilepsy with myoclonic absences with early onset: a follow-up study.
    Journal of child neurology, 1999, Volume: 14, Issue:11

    Topics: Anticonvulsants; Child, Preschool; Developmental Disabilities; Drug Therapy, Combination; Epilepsies

1999
Valproic acid for nonaffective aggression in the mentally retarded.
    The Journal of nervous and mental disease, 1992, Volume: 180, Issue:9

    Topics: Adult; Affect; Aggression; Animals; Female; gamma-Aminobutyric Acid; Humans; Intellectual Disability

1992
Verapamil and valproic acid treatment of prolonged mania.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1992, Volume: 31, Issue:2

    Topics: Adolescent; Arousal; Bipolar Disorder; Drug Therapy, Combination; Humans; Intellectual Disability; M

1992
[A prognostic study of cryptogenic infantile spasms].
    Annales de pediatrie, 1991, Volume: 38, Issue:2

    Topics: Adrenocorticotropic Hormone; Child, Preschool; Cosyntropin; Developmental Disabilities; Electroencep

1991
A potential drug interaction between fluoxetine and valproic acid.
    Journal of clinical psychopharmacology, 1991, Volume: 11, Issue:6

    Topics: Bipolar Disorder; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Intellec

1991
Divalproex-responsive rapid cycling bipolar disorder in a patient with Down's syndrome: implications for the Down's syndrome-mania hypothesis.
    Journal of mental deficiency research, 1991, Volume: 35 ( Pt 2)

    Topics: Adult; Affect; Bipolar Disorder; Diarrhea; Humans; Intellectual Disability; Male; Valproic Acid

1991
[Pellagra in anticonvulsive therapy].
    Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde, 1990, Volume: 138, Issue:12

    Topics: Adult; Anticonvulsants; Drug Therapy, Combination; Epilepsy; Ethosuximide; Female; Humans; Intellect

1990
Valproic acid for the treatment of children with mental retardation and mood symptomatology.
    Pediatrics, 1990, Volume: 86, Issue:3

    Topics: Adolescent; Adolescent Behavior; Affective Disorders, Psychotic; Child; Child Behavior; Drug Evaluat

1990
The use of valproate in the treatment of mentally retarded persons with typical and atypical bipolar disorders.
    The Journal of clinical psychiatry, 1989, Volume: 50 Suppl

    Topics: Adult; Autistic Disorder; Bipolar Disorder; Chronic Disease; Female; Follow-Up Studies; Fragile X Sy

1989
Renal handling of carnitine in children with carnitine deficiency and hyperammonemia associated with valproate therapy.
    The Journal of pediatrics, 1986, Volume: 109, Issue:1

    Topics: Ammonia; Carnitine; Epilepsy; Humans; Infant; Intellectual Disability; Kidney; Metabolic Clearance R

1986
Anticonvulsant medication in a mental handicap hospital: 1972-1982.
    The British journal of psychiatry : the journal of mental science, 1987, Volume: 150

    Topics: Anticonvulsants; Carbamazepine; Female; Hospitals, Psychiatric; Humans; Intellectual Disability; Mal

1987